CSI Market
Sign In | Register

Asp Isotopes Inc (ASPI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ASPI quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Asp Isotopes Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Operating Activities
Income-159.84
Depreciation & amortization1.91
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.06
Increase (Decrease) in Inventories-0.32
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation16.02
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.00
Liabilities Fair Value Adjustment-
Finance Lease Right Of Use Asset Amortization-
Change In Fair Value Of Shares Liability-
Adjustment For Long Term Intercompany Transactions Net Of Tax-
Share Liability For Non Cash Consultant Expense-
Gain Loss Change In Fair Value Of Share Liability0.12
Gain Loss Change In Fair Value Of Convertible Notes Payable123.72
Operating Lease Right Of Use Asset Amortization Expense0.68
Non Cash Interest Income On Note Receivable-2.01
Foreign Currency Transaction Gain Loss Before Tax Intercompany-
Non Cash In- Process Research And Development2.56
Deconsolidation Gain Or Loss Amount0.03
Non Cash Interest Expense On Debt-
Increase Decrease In Operating Lease Liability-
Income taxes-0.05
Unrealized Gain (Loss) on Investments-17.93
Increase (Decrease) in Accounts Receivable-0.48
Increase (Decrease) in Accounts Payable0.78
Increase (Decrease) in Accrued Liabilities0.57
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.83
Other Working Capital-0.69
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.09
Discontinued operations0.00
Net Cash flow from Operating Activities-37.78
Investing Activities
Capital Expenditures-9.65
Sale of Capital Items0.00
Payments to Acquire Short-term Investments-47.75
Short-term Investments Acq.0.00
Real Estate Investments0.00
Prepaid For Property And Equipment-
Payments To Acquire Equity Securities Fv Ni-28.00
Cash Disposed Of Upon Deconsolidation Of Subsidiary-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Business Two, Net of Cash Acquired4.57
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Lease Receivables-29.97
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-110.79
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.17
Long-term debt - borrowings60.25
Long-term debt - repayments-15.76
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock307.26
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock20.80
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-3.47
Finance Lease Principal Payments-0.38
Repayments Of Distribution To Noncontrolling Interest In Variable Interest Entities-0.40
Proceeds From Noncontrolling Interest In Variable Interest Entities-
Proceeds From Collection Of Receivable From Noncontrolling Interest In Vie-
Purchase Of Property And Equipment Included In Accounts Payable0.19
Right Of Use Asset Obtained In Exchange For Operating Lease Liability0.85
Right Of Use Asset Obtained In Exchange For Finance Lease Liability0.31
Seller Financed Portion Of Investment In East Coast Nuclear Pharmacy0.50
Unpaid Financing Fees1.61
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities371.60
Effect of exchange rate on cash flow0.65
Discontinued operations0.00
Free Cash Flow-47.43
Total Cash Flow223.03
4 historic quarters locked

Sign in to unlock the full Asp Isotopes Inc cash flow history.

Sign In Create Free Account

About Asp Isotopes Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-151294

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document